default author photo

Bryan Coburn

University Health Network, University of Toronto

United States

SCHOLARLY PAPERS

1

DOWNLOADS

105

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Peginterferon-Lambda for the Treatment of COVID-19 in Outpatients

Number of pages: 41 Posted: 21 Jan 2021
Viral Hepatitis Care Network (VIRCAN), Faculty of Medicine, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, University of Toronto - Department of Laboratory Medicine and Pathobiology, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, University Health Network, University of Toronto, Division of Infectious Diseases, William Osler Health System, University Health Network, University of Toronto, Michael Garron Hospital, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, University of Toronto - Saint Michael's Hospital, Trillium Health Partners, University Health Network, University of Toronto, University of Toronto - Transplant Infectious Diseases and Multi-Organ Transplant Program, University of Toronto - Transplant Infectious Diseases and Multi-Organ Transplant Program, Sunnybrook Health Sciences Centre, University of Toronto, North York General Hospital, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, University of Toronto - Toronto Centre for Liver Disease, Sunnybrook Health Sciences Centre, University of Toronto, Sunnybrook Health Sciences Centre, University of Toronto, Eiger BioPharmaceuticals, Eiger BioPharmaceuticals, The Li Ka Shing Institute of Virology, University of Alberta, The Li Ka Shing Institute of Virology, University of Alberta, Departments of Medicine and Microbiology & Immunology, Stanford University School of Medicine, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto and Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto
Downloads 105 (664,543)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Type III Interferon, Antiviral Therapy, Viral Load, Outpatients